Articoli con mandati relativi all'accesso pubblico - Andrew BoulleUlteriori informazioni
Non disponibili pubblicamente: 5
Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis
AM Demers, A Boulle, R Warren, S Verver, P Van Helden, MA Behr, ...
The International Journal of Tuberculosis and Lung Disease 14 (8), 1016-1023, 2010
Mandati: Fonds de recherche du Québec - Santé
Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability
G Meintjes, A Boulle
Expert review of anti-infective therapy 10 (7), 737-741, 2012
Mandati: US National Institutes of Health
The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa
ST De Beer, MA Davies, F Phelanyane, HE Jones, SM Ingle, BS Eley, ...
The Pediatric Infectious Disease Journal 43 (11), 1061-1064, 2024
Mandati: Bill & Melinda Gates Foundation, UK Research & Innovation
Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa …
P Nyakato, A Boulle, R Wood, B Eley, H Rabie, M Egger, CT Yiannoutsos, ...
The Pediatric Infectious Disease Journal 43 (5), 430-436, 2024
Mandati: Wellcome Trust
Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa: population-based cohort study.
AL Slogrove, A Bovu, S de Beer, F Phelanyane, PL Williams, A Heekes, ...
AIDS (London, England), 2023
Mandati: US National Institutes of Health
Disponibili pubblicamente: 180
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ...
The Lancet 399 (10323), 437-446, 2022
Mandati: Bill & Melinda Gates Foundation, Department of International Development, UK …
Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa
Clinical Infectious Diseases 73 (7), e2005-e2015, 2021
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
LF Johnson, J Mossong, RE Dorrington, M Schomaker, CJ Hoffmann, ...
PLoS Medicine 10 (4), e1001418, 2013
Mandati: US National Institutes of Health, Wellcome Trust
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
MWG Brinkhof, F Dabis, L Myer, DR Bangsberg, A Boulle, D Nash, ...
Bulletin of the World Health Organization 86 (7), 559-567, 2008
Mandati: US National Institutes of Health
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, G van Cutsem, ...
The Lancet 384 (9944), 682-690, 2014
Mandati: UK Medical Research Council, Wellcome Trust
Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study
M Cornell, M Schomaker, DB Garone, J Giddy, CJ Hoffmann, R Lessells, ...
PLoS Medicine 9 (9), e1001304, 2012
Mandati: US National Institutes of Health
Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa
M Egger, DK Ekouevi, C Williams, RE Lyamuya, H Mukumbi, P Braitstein, ...
International journal of epidemiology 41 (5), 1256-1264, 2012
Mandati: US National Institutes of Health
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007
M Cornell, A Grimsrud, L Fairall, MP Fox, G van Cutsem, J Giddy, R Wood, ...
Aids 24 (14), 2263-2270, 2010
Mandati: US National Institutes of Health
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
M May, A Boulle, S Phiri, E Messou, L Myer, R Wood, O Keiser, ...
The Lancet 376 (9739), 449-457, 2010
Mandati: Swiss National Science Foundation, US National Institutes of Health
Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa
MA Luque-Fernandez, G Van Cutsem, E Goemaere, K Hilderbrand, ...
PloS one 8 (2), e56088, 2013
Mandati: US National Institutes of Health
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
MWG Brinkhof, A Boulle, R Weigel, E Messou, C Mathers, C Orrell, ...
PLoS medicine 6 (4), e1000066, 2009
Mandati: US National Institutes of Health
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
P Braitstein, A Boulle, D Nash, MWG Brinkhof, F Dabis, C Laurent, ...
Journal of women's health 17 (1), 47-55, 2008
Mandati: Canadian Institutes of Health Research
Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa-a cross sectional study
T Oni, E Youngblood, A Boulle, N McGrath, RJ Wilkinson, NS Levitt
BMC infectious diseases 15, 1-8, 2015
Mandati: UK Medical Research Council, National Institute for Health Research, UK …
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
O Keiser, K Anastos, M Schechter, E Balestre, L Myer, A Boulle, ...
Trop Med Int Health 13 (7), 870-879, 2008
Mandati: US National Institutes of Health
Antiretroviral therapy and early mortality in South Africa
A Boulle, P Bock, M Osler, K Cohen, L Channing, K Hilderbrand, ...
Bulletin of the World Health Organization 86 (9), 678-687, 2008
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software